Celebrity Peptide Protocols
What public figures have discussed about peptides. Direct quotes, podcast sources, and how their statements compare to the research evidence.
10 profiles documented
Andrew Huberman
What Stanford neuroscientist Andrew Huberman has discussed about peptides on his podcast and in interviews, with his scientific analysis of mechanisms, evidence levels, and practical protocols.
Ben Greenfield
A guide to the peptides Ben Greenfield has discussed and used in his performance optimization protocols, from healing peptides to nootropics and growth hormone optimization.
Dr. Craig Koniver
A guide to the peptide protocols Dr. Craig Koniver has discussed publicly, including his clinical approach to BPC-157, growth hormone peptides, NAD+, and longevity interventions.
Dana White
How UFC CEO Dana White's public health transformation brought attention to peptide therapy, including the protocols he has reportedly followed and the results he has shared.
Dave Asprey
What biohacking pioneer Dave Asprey has discussed about peptide use for anti-aging, gut health, and performance optimization, from BPC-157 to longevity peptides.
David Sinclair
How Harvard longevity researcher David Sinclair views peptides within the broader context of aging science, including his approach to growth hormone optimization and cellular repair.
Derek (More Plates More Dates)
A detailed guide to the peptides Derek (MPMD) has covered on his YouTube channel and website, known for thorough pharmacological analysis and harm reduction focus.
Gary Brecka
A guide to Gary Brecka's approach to peptide therapy within his 10X Health System, including the Super Human Protocol and his work with high-profile clients.
Joe Rogan
A comprehensive guide to the peptides Joe Rogan has publicly discussed on his podcast and in interviews, including his reported personal use, the context of his discussions, and what the research actually shows.
Peter Attia
How longevity physician Peter Attia evaluates peptides through his evidence-based framework, including his cautious approach to BPC-157 and growth hormone optimization.